BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Camzyos (Mavacamten) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Camzyos (Mavacamten)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07004972-660@assetmemo.bio
DTSTAMP:20261121T005649Z
DTSTART;VALUE=DATE:20271213
DTEND;VALUE=DATE:20271214
SUMMARY:Camzyos (Mavacamten): Phase 4 readout est. (NCT07004972)
DESCRIPTION:Camzyos (Mavacamten)\, phase 4\, Hypertrophic Cardiomyopathy.\n
 Study: A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardi
 omyopathy in India (ROVER)\nEstimated primary completion: 13 December 2027
 . This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, a
 nd it can move.\nDrug page: https://assetmemo.bio/drug/mavacamten#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07004972
URL:https://assetmemo.bio/drug/mavacamten#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07120776-660@assetmemo.bio
DTSTAMP:20261121T005649Z
DTSTART;VALUE=DATE:20281031
DTEND;VALUE=DATE:20281101
SUMMARY:Camzyos (Mavacamten): Phase na readout est. (NCT07120776)
DESCRIPTION:Camzyos (Mavacamten)\, phase na\, Hypertrophic Cardiomyopathy.\
 nStudy: Positron Emission Tomography to Assess the Effect of Camzyos on Is
 chaemia in HOCM: PEACH Trial\nEstimated primary completion: October 2028. 
 This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and
  it can move.\nDrug page: https://assetmemo.bio/drug/mavacamten#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07120776
URL:https://assetmemo.bio/drug/mavacamten#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07815301-660@assetmemo.bio
DTSTAMP:20261121T005649Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Camzyos (Mavacamten): Phase na readout est. (NCT07815301)
DESCRIPTION:Camzyos (Mavacamten)\, phase na\, Hypertrophic Cardiomyopathy.\
 nStudy: Gradual Tapering or Discontinuation of Beta-Blockers After Stabili
 zation With Mavacamten Therapy\nEstimated primary completion: December 202
 8. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, 
 and it can move.\nDrug page: https://assetmemo.bio/drug/mavacamten#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT07815301
URL:https://assetmemo.bio/drug/mavacamten#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07940777-660@assetmemo.bio
DTSTAMP:20261121T005649Z
DTSTART;VALUE=DATE:20290721
DTEND;VALUE=DATE:20290722
SUMMARY:Camzyos (Mavacamten): Phase 3 readout est. (NCT07940777)
DESCRIPTION:Camzyos (Mavacamten)\, phase 3\, Hypertrophic Cardiomyopathy.\n
 Study: A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults
  With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HC
 M)\nEstimated primary completion: 21 July 2029. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/mavacamten#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT07940777
URL:https://assetmemo.bio/drug/mavacamten#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07807384-660@assetmemo.bio
DTSTAMP:20261121T005649Z
DTSTART;VALUE=DATE:20290930
DTEND;VALUE=DATE:20291001
SUMMARY:Camzyos (Mavacamten): Phase 4 readout est. (NCT07807384)
DESCRIPTION:Camzyos (Mavacamten)\, phase 4\, Hypertrophic Cardiomyopathy.\n
 Study: Efficacy and Safety of an LVEF-Guided Mavacamten Dose Up-Titration 
 Strategy in Chinese Patients With Symptomatic Obstructive Hypertrophic Car
 diomyopathy\nEstimated primary completion: September 2029. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/mavacamten#upcoming-events\nRegistry
  record: https://clinicaltrials.gov/study/NCT07807384
URL:https://assetmemo.bio/drug/mavacamten#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
